Treatment with statins may be considered in ESRD patients for primary prevention of cardiovascular disease.
Manca-di-Villahermosa
Simone
S
Department of Internal Medicine, Tor Vergata University, Rome, Italy, and Nephrology and Dialysis Unit, Tor Vergata University Hospital, Rome, Italy.
Taccone-Gallucci
Massimo
M
Department of Internal Medicine, Tor Vergata University, Rome, Italy, and Nephrology and Dialysis Unit, Tor Vergata University Hospital, Rome, Italy. Electronic address: taccone.gallucci@med.uniroma2.it.
Maccarrone
Mauro
M
Department of Biomedical Sciences, University of Teramo, Italy, and European Center for Brain Research (CERC)/S. Lucia Foundation, Rome, Italy.
D002318:Cardiovascular Diseases / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000150:complications / Q000188:drug therapy* / Q000628:therapy; D006435:Renal Dialysis
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors